back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-08 13:58 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
383,332 | |
| Filed 2024-02-08 13:57 Tx date 2024-02-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-250,000 vol |
0 | |
| Filed 2024-02-04 10:55 Tx date 2024-01-30 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2024-01-04 15:51 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+66,668 vol |
133,332 | |
| Filed 2024-01-04 15:50 Tx date 2024-01-02 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-66,668 vol |
0 | |
| Filed 2023-05-09 19:17 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Warrants
57 - Exercise of rights
|
+24,000 vol |
24,000 | |
| Filed 2023-05-09 19:16 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-09 19:15 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$6,000
+24,000 vol $0.25 each |
48,000 | |
| Filed 2023-05-09 19:15 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Rights
57 - Exercise of rights
|
-24,000 vol |
0 | |
| Filed 2023-05-09 19:13 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+33,332 vol |
33,332 | |
| Filed 2023-05-09 19:13 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-09 19:12 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,333
+33,332 vol $0.25 each |
66,664 | |
| Filed 2023-05-09 19:12 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-33,332 vol |
0 | |
| Filed 2023-04-17 22:03 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Rights
56 - Grant of rights
|
+24,000 vol |
24,000 | |
| Filed 2023-04-17 22:03 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Holder: Eldee Foundation (Indirect Ownership)
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-17 22:01 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+33,332 vol |
33,332 | |
| Filed 2023-04-17 22:00 Tx date 2021-09-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-14 13:35 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+50,001 vol |
66,668 | |
| Filed 2023-03-14 13:34 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+45,000 vol |
100,000 | |
| Filed 2023-03-14 13:33 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Bloomfield, Harry J.F.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+30,000 vol |
55,000 |